152 related articles for article (PubMed ID: 22441510)
21. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis.
Kim MY; Baik SK; Yea CJ; Lee IY; Kim HJ; Park KW; Kim HK; Suk KT; Kim JW; Kim HS; Kwon SO; Cha SH; Kim YJ; Koh SB; Chang SJ
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1241-6. PubMed ID: 19455045
[TBL] [Abstract][Full Text] [Related]
22. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
Windram JD; Loh PH; Rigby AS; Hanning I; Clark AL; Cleland JG
Am Heart J; 2007 Jun; 153(6):1048-55. PubMed ID: 17540208
[TBL] [Abstract][Full Text] [Related]
23. Adhesion molecules as a prognostic marker of liver cirrhosis.
Girón-González JA; Martínez-Sierra C; Rodriguez-Ramos C; Rendón P; Macías MA; Fernández-Gutiérrez C; Díaz F; Martín-Herrera L
Scand J Gastroenterol; 2005 Feb; 40(2):217-24. PubMed ID: 15764154
[TBL] [Abstract][Full Text] [Related]
24. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
25. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
Kondo M; Miszputen SJ; Leite-mor MM; Parise ER
Hepatogastroenterology; 1995; 42(5):542-5. PubMed ID: 8751212
[TBL] [Abstract][Full Text] [Related]
26. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis.
Lo Iacono O; Rincón D; Hernando A; Ripoll C; Catalina MV; Salcedo M; Clemente G; Gomez J; Nuñez O; Matilla A; Bañares R
Liver Int; 2008 Sep; 28(8):1129-35. PubMed ID: 18482273
[TBL] [Abstract][Full Text] [Related]
28. The relationship between inflammation and arterial stiffness in patients with essential hypertension.
Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M
Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996
[TBL] [Abstract][Full Text] [Related]
29. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
[TBL] [Abstract][Full Text] [Related]
30. Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient.
Genovesi S; Prata Pizzala DM; Pozzi M; Ratti L; Milanese M; Vincenti A; Stella A; Mancia G
Liver Int; 2010 Feb; 30(2):232-9. PubMed ID: 19793198
[TBL] [Abstract][Full Text] [Related]
31. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
32. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL
Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between hemodynamic parameters of the portal circulation in cirrhotic patients].
Bretagne JF; Bourguet P; Morisot D; Duvauferrier R; Darnault P; Gastard J
Gastroenterol Clin Biol; 1985 Oct; 9(10):674-8. PubMed ID: 4065489
[TBL] [Abstract][Full Text] [Related]
35. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.
Pietri P; Vyssoulis G; Vlachopoulos C; Zervoudaki A; Gialernios T; Aznaouridis K; Stefanadis C
J Hypertens; 2006 Nov; 24(11):2231-8. PubMed ID: 17053545
[TBL] [Abstract][Full Text] [Related]
36. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure.
Yin WH; Chen JW; Jen HL; Chiang MC; Huang WP; Feng AN; Young MS; Lin SJ
Am Heart J; 2004 May; 147(5):931-8. PubMed ID: 15131554
[TBL] [Abstract][Full Text] [Related]
37. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
Habib SS
J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
[TBL] [Abstract][Full Text] [Related]
38. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis.
Zietz B; Lock G; Plach B; Drobnik W; Grossmann J; Schölmerich J; Straub RH
Eur J Gastroenterol Hepatol; 2003 May; 15(5):495-501. PubMed ID: 12702906
[TBL] [Abstract][Full Text] [Related]
39. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
[TBL] [Abstract][Full Text] [Related]
40. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
